Feedback / Questions
gedatolisib (PF-05212384) - Celcuity
https://www.globenewswire.com/news-release/2025/07/28/3122331/0/en/Celcuity-Announces-Clinically-Meaningful-Improvement-in-Both-Progression-Free-Survival-PFS-Primary-Endpoints-from-PIK3CA-Wild-Type-Cohort-of-Phase-3-VIKTORIA-1-Trial.html
Jul 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next